JP Morgan Chase
EVMN

JP Morgan Chase’s Evommune Inc EVMN Stock Holding History

JP Morgan Chase’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Buy
1,553,132
+93,712
+6% +$2.18M ﹤0.01% 2086
2026
Q1 		$32.1M Buy
1,459,420
+150,519
+11% +$3.4M ﹤0.01% 1688
2025
Q4 		$22.4M Buy
+1,308,901
New +$24.6M ﹤0.01% 1967

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

JP Morgan Chase's EVMN Position: Q2 2026 in Review

JP Morgan Chase increased its Evommune Inc (EVMN) stake by 6.4% in Q2 2026, buying an estimated $2.18M and bringing the position to 1,553,132 shares worth $23.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2086.

JP Morgan Chase first reported a position in EVMN in Q4 2025 and has held it in 3 quarters since. The position peaked at $32.1M in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • JP Morgan Chase held 1,553,132 shares of Evommune Inc worth $23.4M as of Q2 2026.
  • JP Morgan Chase bought 93,712 Evommune Inc shares in Q2 2026, an estimated $2.18M.
  • Evommune Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2086 holding.
  • JP Morgan Chase first reported a position in Evommune Inc in Q4 2025 and has held it in 3 quarters since.
  • JP Morgan Chase's Evommune Inc position peaked at $32.1M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.